Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer

Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer

This clinical trial studies fluorine F-18 sodium fluoride positron emission tomography (PET)/computed tomography (CT) in diagnosing bone tumors in patients with cancer. Diagnostic procedures, such as fluorine F-18 sodium fluoride PET/CT, may help find and diagnose bone cancer

The objective of the study is to use 18F sodium fluoride (fluorine F-18 sodium fluoride) PET/CT scanning to detect and characterize lesions in patients who have suspected skeletal malignancy. We hypothesize that scanning with 18F-NaF (fluorine F-18 sodium fluoride) is more sensitive for skeletal abnormalities and may better characterize lesions than conventional imaging.

Inclusion Criteria:

• Patients referred for evaluation of suspected skeletal cancer
• Patients must understand and voluntarily sign an informed consent form after the contents have been fully explained to them

Exclusion Criteria:

• Patients who cannot complete a PET/CT scan
• Pregnant women
• Healthy volunteers